Posted in | News | Imaging

Wavien and Meiloon Plan to Launch Ultra-Short-Throw Projector

Wavien, Inc. and Meiloon Industrial Co., Ltd. today announce a joint plan to introduce an Ultra-Short-Throw (UST) projector for the educational and home theatre markets.

"Wavien's DPR technology offers a longer lifetime, significantly improved and maintained brightness, and higher efficiency in projection applications when used with ultra high pressure mercury from qualified vendors," stated Dr. Kenneth Li, President and CEO of Wavien, Inc., who is also the inventor of the DPR technology. Dr. Li added: "This unique patented design enables a significant reduction in the cost of projector operation, which is especially important in classrooms where projector usage is very high and home theatre applications where trouble-free operation is essential."

"Short throw projection is the market trend of projection display for large screen display at low cost while mobility and space are considered, and Meiloon is one of the ODM leaders in the market right now," said Dr. Michael Tang, head of Opto-electronics BU of Meiloon. "Lamp life and replacement cost is always a big issue for projectors especially in the areas of high service and labor cost such as North America and Europe, where short throw projectors with much longer lamp life is highly expected." Dr. Tang added, "Eventually LED lighting is the solution for such problem, but current efficiency is not good enough when over 1,000 lumens are demanded, so DPR can be a nice solution before significant improvement by LED lighting."

Last summer Wavien and Texas Instruments announced a co-marketing effort using Wavien's DPR technology for projectors aimed at the educational market.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.